Montana House Bill HB600

Montana 2025 Regular Session

• Introduced: 2/20/25
• Refer: 2/20/25
• Engrossed: 3/7/25
• Refer: 3/14/25
• Enrolled: 4/15/25
• Passed: 5/1/25

Caption

Authorize emergency use of albuterol in a school setting

Impact

The legislation amends existing Montana law to better facilitate the management of asthma and severe allergies by enabling schools to stock a ready supply of albuterol for emergencies. It requires schools to develop protocols for training staff and maintaining this medication, as well as guidelines for how to respond in situations of respiratory distress. The bill also stipulates that schools will not be held liable for injuries resulting from the administration of the stock albuterol unless gross negligence occurs, thus providing a legal safety net for school personnel acting in good faith.

Summary

House Bill 600 is designed to address emergency medication administration in schools by allowing both public and nonpublic schools to maintain a supply of stock albuterol, a quick-relief medicine for asthma and respiratory distress. This bill seeks to streamline the protocols for administering this medication during medical emergencies involving students, ensuring they receive timely treatment while minimizing delays due to procedural strictness. By establishing clear guidelines, HB600 aims to enhance the safety of students with respiratory conditions, particularly during school hours and school-sponsored activities.

Sentiment

Overall, the sentiment surrounding HB600 is supportive, particularly among parents and educators concerned about the health and safety of students with asthma and severe allergies. Many stakeholders acknowledge the necessity of having rapid access to emergency medications. However, there are also concerns about the potential implications for liability and the responsibility schools must shoulder in managing health emergencies, sparking discussions about the adequacy of training and preparedness among school staff.

Contention

Notable points of contention include the liability protections offered to schools and whether they are sufficient to encourage stockpiling and administering emergency medications. Some critics argue that while the bill provides a framework for emergency responses, it may inadvertently lead to hesitancy among staff to administer medication due to fears of liability. Another aspect of debate is the logistical and financial implications for schools, as they may need to invest in training and inventory management without additional state funding, raising questions about equity in health responses across diverse school environments.